Sarilumab

Kevzara Injection Gets FDA Approval for Rheumatoid Arthritis

Kevzara Injection Gets FDA Approval for Rheumatoid Arthritis

By

Regeneron and Sanofi announced that the FDA has approved Kevzara (sarilumab) injection to treat adults with moderate to severe rheumatoid arthritis.

Sign Up for Free e-Newsletters